| REVIEW ARTICLE |
|
| Year : 2011 | Volume
: 2
| Issue : 2 | Page : 88-93 |
|
|
Intellectual property rights: An overview and implications in pharmaceutical industry
Chandra Nath Saha1, Sanjib Bhattacharya2
1 Quality Assurance Department, Claris Lifesciences Ltd., Ahmedabad, Gujarat, India
2 Pharmacognosy Division, Bengal School of Technology (A College of Pharmacy), Sugandha, Hooghly, West Bengal, India
Correspondence Address:
Sanjib Bhattacharya
Pharmacognosy Division, Bengal School of Technology (A College of Pharmacy), Delhi Road, Sugandha, Hooghly - 712 102, West Bengal
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2231-4040.82952
|
|
|
Intellectual property rights (IPR) have been defined as ideas, inventions, and creative expressions based on which there is a public willingness to bestow the status of property. IPR provide certain exclusive rights to the inventors or creators of that property, in order to enable them to reap commercial benefits from their creative efforts or reputation. There are several types of intellectual property protection like patent, copyright, trademark, etc. Patent is a recognition for an invention, which satisfies the criteria of global novelty, non-obviousness, and industrial application. IPR is prerequisite for better identification, planning, commercialization, rendering, and thereby protection of invention or creativity. Each industry should evolve its own IPR policies, management style, strategies, and so on depending on its area of specialty. Pharmaceutical industry currently has an evolving IPR strategy requiring a better focus and approach in the coming era. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
